<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <updateDate>2017-06-19T21:15:23Z</updateDate>
    <recordedVotes />
    <laws />
    <sponsors>
      <item>
        <middleName>Ray</middleName>
        <lastName>Lujan</lastName>
        <party>D</party>
        <firstName>Ben</firstName>
        <state>NM</state>
        <bioguideId>L000570</bioguideId>
        <fullName>Rep. Lujan, Ben Ray [D-NM-3]</fullName>
        <byRequestType />
        <identifiers>
          <bioguideId>L000570</bioguideId>
          <lisID>1939</lisID>
          <gpoId>8058</gpoId>
        </identifiers>
        <district>3</district>
      </item>
    </sponsors>
    <committees>
      <billCommittees>
        <item>
          <name>Energy and Commerce Committee</name>
          <type>Standing</type>
          <chamber>House</chamber>
          <subcommittees>
            <item>
              <name>Health Subcommittee</name>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2017-03-03T18:53:14Z</date>
                </item>
              </activities>
              <systemCode>hsif14</systemCode>
            </item>
          </subcommittees>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-02-28T15:02:30Z</date>
            </item>
          </activities>
          <systemCode>hsif00</systemCode>
        </item>
      </billCommittees>
    </committees>
    <title>CCM-CARE Act</title>
    <notes />
    <introducedDate>2017-02-28</introducedDate>
    <amendments />
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Cardiovascular and respiratory health</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Health care quality</name>
          </item>
          <item>
            <name>Health facilities and institutions</name>
          </item>
          <item>
            <name>Health information and medical records</name>
          </item>
          <item>
            <name>Health promotion and preventive care</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Neurological disorders</name>
          </item>
          <item>
            <name>Research administration and funding</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <committeeReports />
    <calendarNumbers />
    <congress>115</congress>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <text><![CDATA[<p><b>Cerebral Cavernous Malformations Clinical Awareness, Research, and Education Act of 2017 or the CCM-CARE Act</b></p> <p>This bill amends the Public Health Service Act to require the National Institutes of Health (NIH) to strengthen and coordinate its efforts concerning cerebral cavernous malformation (CCM). (CCM is a condition in which blood vessels in the brain and spinal cord become enlarged, which can lead to seizures, paralysis, hearing or vision loss, or bleeding in the brain.) The NIH may award grants and enter into cooperative agreements for CCM research.</p> <p>The NIH must: (1) award grants and contracts to plan and provide support for a network of CCM Clinical Research Centers; (2) identify and support additional centers to facilitate medical research to develop a cure for CCM and enhance medical care for CCM; and (3) convene a Cerebral Cavernous Malformations Research Consortium to develop programs for clinicians, scientists, and patients.</p> <p>The Centers for Disease Control and Prevention may award grants and enter into cooperative agreements for the collection, analysis, and reporting of data on CCM.</p> <p>The Department of Health and Human Services must award grants and enter into cooperative agreements for epidemiological activities related to CCM and must provide for a national CCM surveillance program.</p> <p>The Food and Drug Administration must, in order to hasten clinical trials for CCM, coordinate with clinical centers, investigators, and advocates to support: (1) qualification of biomarkers, (2) qualification of patient reported outcome measures for quality of life, (3) investigational new drug applications, and (4) adaptive trial designs for rare disease research and expedited review of medications.</p>]]></text>
          <lastSummaryUpdateDate>2017-03-07T18:20:46Z</lastSummaryUpdateDate>
          <name>Introduced in House</name>
          <actionDate>2017-02-28</actionDate>
          <actionDesc>Introduced in House</actionDesc>
          <updateDate>2017-02-28T05:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
    <version>1.0.0</version>
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. BEN RAY LUJAN of New Mexico:H.R. 1255.Congress has the power to enact this legislation pursuantto the following:Article I, Section VIII[Page H1393]</pre>]]></constitutionalAuthorityStatementText>
    <relatedBills>
      <item>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Identical bill</type>
          </item>
        </relationshipDetails>
        <number>475</number>
        <latestTitle>CCM-CARE Act</latestTitle>
        <congress>115</congress>
        <latestAction>
          <actionDate>2017-02-28</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <type>S</type>
      </item>
    </relatedBills>
    <cosponsors>
      <item>
        <state>NM</state>
        <firstName>Michelle</firstName>
        <identifiers>
          <lisID>2146</lisID>
          <gpoId />
          <bioguideId>L000580</bioguideId>
        </identifiers>
        <party>D</party>
        <sponsorshipDate>2017-02-28</sponsorshipDate>
        <middleName />
        <sponsorshipWithdrawnDate />
        <lastName>Lujan Grisham</lastName>
        <bioguideId>L000580</bioguideId>
        <fullName>Rep. Lujan Grisham, Michelle [D-NM-1]</fullName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <district>1</district>
      </item>
      <item>
        <state>NM</state>
        <firstName>Stevan</firstName>
        <identifiers>
          <bioguideId>P000588</bioguideId>
          <lisID>1738</lisID>
          <gpoId>8057</gpoId>
        </identifiers>
        <party>R</party>
        <sponsorshipDate>2017-02-28</sponsorshipDate>
        <middleName />
        <sponsorshipWithdrawnDate />
        <lastName>Pearce</lastName>
        <bioguideId>P000588</bioguideId>
        <fullName>Rep. Pearce, Stevan [R-NM-2]</fullName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <district>2</district>
      </item>
    </cosponsors>
    <billNumber>1255</billNumber>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <originChamber>House</originChamber>
    <cboCostEstimates />
    <billType>HR</billType>
    <actions>
      <item>
        <actionDate>2017-03-03</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <type>IntroReferral</type>
        <actionDate>2017-02-28</actionDate>
        <links />
      </item>
      <item>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <text>Introduced in House</text>
        <committee />
        <type>IntroReferral</type>
        <actionDate>2017-02-28</actionDate>
        <links />
      </item>
      <item>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <text>Introduced in House</text>
        <committee />
        <type>IntroReferral</type>
        <actionDate>2017-02-28</actionDate>
        <links />
      </item>
      <actionTypeCounts>
        <placeholderTextForH>1</placeholderTextForH>
        <introducedInTheHouse>1</introducedInTheHouse>
        <billReferrals>1</billReferrals>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <createDate>2017-03-01T05:20:53Z</createDate>
    <titles>
      <item>
        <parentTitleType />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <title>CCMâ€“CARE Act</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <parentTitleType />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <title>Cerebral Cavernous Malformations Clinical Awareness, Research, and Education Act of 2017</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <title>CCM-CARE Act</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <parentTitleType />
        <titleType>Short Titles as Introduced</titleType>
        <title>Cerebral Cavernous Malformations Clinical Awareness, Research, and Education Act of 2017</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <title>To increase research, education, and treatment for cerebral cavernous malformations.</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <parentTitleType />
        <titleType>Display Title</titleType>
        <title>CCM-CARE Act</title>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <latestAction>
      <actionDate>2017-03-03</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
      <links />
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

